| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.991 | 0.001 | 0.991 | Androgen agonist | 0.822 0.001 DBMET02306 0.784 0.001 DBMET02307 | ||
| 0.987 | 0 | 0.987 | Anabolic | 0.45 0.001 DBMET02306 0.397 0.001 DBMET02307 | ||
| 0.953 | 0.001 | 0.953 | Aromatase inhibitor | 0.605 0.003 DBMET02306 0.475 0.003 DBMET02307 | ||
| 0.945 | 0.002 | 0.945 | Androgen antagonist | 0.582 0.003 DBMET02306 0.403 0.005 DBMET02307 | ||
| 0.879 | 0.001 | 0.879 | Progesterone antagonist | 0.391 0.003 DBMET02306 0.386 0.003 DBMET02307 | ||
| 0.856 | 0.002 | 0.856 | Estrogen agonist | 0.852 0.002 DBMET02306 0.707 0.003 DBMET02307 | ||
| 0.813 | 0.001 | 0.813 | Progesterone agonist | 0.589 0.001 DBMET02306 0.592 0.001 DBMET02307 | ||
| 0.781 | 0.018 | 0.861 | Antiinflammatory | 0.817 0.013 DBMET02306 0.861 0.008 DBMET02307 | DBMET02307 | |
| 0.728 | 0.006 | 0.728 | Aldehyde oxidase inhibitor | 0.181 0.115 DBMET02306 0.162 0.129 DBMET02307 | ||
| 0.729 | 0.018 | 0.825 | Transcription factor NF kappa B inhibitor | 0.309 0.09 DBMET02306 0.825 0.011 DBMET02307 | DBMET02307 | |
| 0.678 | 0.034 | 0.802 | Apoptosis agonist | 0.478 0.081 DBMET02306 0.802 0.016 DBMET02307 | DBMET02307 | |
| 0.616 | 0.002 | 0.616 | Lipocortins synthesis antagonist | 0.514 0.004 DBMET02306 0.518 0.003 DBMET02307 | ||
| 0.579 | 0.002 | 0.579 | Glucocorticoid antagonist | 0.301 0.003 DBMET02306 0.294 0.003 DBMET02307 | ||
| 0.578 | 0.004 | 0.578 | Estrogen antagonist | 0.343 0.005 DBMET02306 0.298 0.006 DBMET02307 | ||
| 0.486 | 0.003 | 0.486 | Mineralocorticoid receptor antagonist | 0.152 0.005 DBMET02306 0.132 0.005 DBMET02307 | ||
| 0.507 | 0.031 | 0.594 | Immunosuppressant | 0.389 0.068 DBMET02306 0.594 0.014 DBMET02307 | DBMET02307 | |
| 0.471 | 0.018 | 0.608 | Nitric oxide antagonist | 0.391 0.027 DBMET02306 0.608 0.009 DBMET02307 | DBMET02307 | |
| 0.457 | 0.007 | 0.457 | Sodium/bile acid cotransporter inhibitor | 0.436 0.009 DBMET02306 0.406 0.015 DBMET02307 | ||
| 0.449 | 0.004 | 0.449 | Estrogen receptor alpha antagonist | 0.101 0.026 DBMET02306 | ||
| 0.45 | 0.01 | 0.45 | Diuretic | 0.122 0.102 DBMET02306 0.388 0.014 DBMET02307 | ||
| 0.457 | 0.019 | 0.457 | Hypoxia-inducible factor 1 alpha inhibitor | 0.213 0.137 DBMET02306 0.41 0.028 DBMET02307 | ||
| 0.433 | 0.004 | 0.433 | Estrogen receptor beta antagonist | 0.225 0.008 DBMET02306 0.152 0.015 DBMET02307 | ||
| 0.421 | 0.014 | 0.469 | Anesthetic general | 0.469 0.01 DBMET02307 | DBMET02307 | |
| 0.404 | 0.003 | 0.404 | Estrogen receptor alpha agonist | 0.283 0.004 DBMET02306 0.235 0.004 DBMET02307 | ||
| 0.341 | 0.004 | 0.341 | Estrogen receptor beta agonist | 0.196 0.005 DBMET02306 0.167 0.006 DBMET02307 | ||
| 0.356 | 0.053 | 0.449 | Apoptosis antagonist | 0.285 0.096 DBMET02306 0.449 0.028 DBMET02307 | DBMET02307 | |
| 0.251 | 0.003 | 0.251 | Aldosterone antagonist | 0.051 0.028 DBMET02306 | ||
| 0.246 | 0.005 | 0.246 | Antineoplastic alkaloid | 0.193 0.016 DBMET02306 0.22 0.009 DBMET02307 | ||
| 0.245 | 0.007 | 0.245 | Arachidonic acid antagonist | 0.165 0.07 DBMET02306 0.158 0.079 DBMET02307 | ||
| 0.224 | 0.034 | 0.224 | Interferon gamma antagonist | 0.178 0.052 DBMET02307 | ||
| 0.193 | 0.005 | 0.193 | 5-Alpha-reductase inhibitor | 0.063 0.015 DBMET02307 | ||
| 0.193 | 0.024 | 0.193 | Farnesoid X receptor antagonist | 0.139 0.066 DBMET02306 0.13 0.082 DBMET02307 | ||
| 0.166 | 0.005 | 0.166 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.197 | 0.037 | 0.197 | Bone formation stimulant | 0.117 0.088 DBMET02306 0.191 0.038 DBMET02307 | ||
| 0.196 | 0.043 | 0.226 | Lipid peroxidase inhibitor | 0.226 0.032 DBMET02307 | DBMET02307 | |
| 0.317 | 0.176 | 0.438 | Caspase 9 stimulant | 0.438 0.089 DBMET02307 | DBMET02307 | |
| 0.144 | 0.004 | 0.144 | Estrone sulfatase inhibitor | 0.13 0.004 DBMET02306 0.055 0.007 DBMET02307 | ||
| 0.137 | 0.004 | 0.137 | RNA-directed RNA polymerase stimulant | 0.072 0.009 DBMET02306 0.07 0.009 DBMET02307 | ||
| 0.223 | 0.091 | 0.354 | DNA synthesis inhibitor | 0.354 0.029 DBMET02307 | DBMET02307 | |
| 0.195 | 0.068 | 0.377 | Hepatoprotectant | 0.202 0.064 DBMET02306 0.377 0.015 DBMET02307 | DBMET02307 | |
| 0.138 | 0.034 | 0.273 | Antineoplastic antibiotic | 0.146 0.032 DBMET02306 0.273 0.012 DBMET02307 | DBMET02307 | |
| 0.144 | 0.041 | 0.144 | Microtubule formation inhibitor | 0.126 0.054 DBMET02307 | ||
| 0.104 | 0.005 | 0.104 | Lipocortins synthesis agonist | 0.084 0.011 DBMET02306 0.095 0.007 DBMET02307 | ||
| 0.113 | 0.021 | 0.162 | Na+ K+ transporting ATPase inhibitor | 0.08 0.05 DBMET02306 0.162 0.004 DBMET02307 | DBMET02307 | |
| 0.093 | 0.005 | 0.093 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.027 0.01 DBMET02306 | ||
| 0.104 | 0.028 | 0.104 | Keratolytic | |||
| 0.116 | 0.041 | 0.116 | Prolactin inhibitor | |||
| 0.071 | 0.002 | 0.071 | Progesterone receptor A antagonist | |||
| 0.189 | 0.123 | 0.409 | Antioxidant | 0.409 0.033 DBMET02307 | DBMET02307 | |
| 0.139 | 0.076 | 0.139 | Pregnane X receptor agonist | |||
| 0.123 | 0.06 | 0.142 | Monophenol monooxygenase inhibitor | 0.142 0.05 DBMET02307 | DBMET02307 | |
| 0.143 | 0.08 | 0.282 | NOS3 expression enhancer | 0.282 0.021 DBMET02307 | DBMET02307 | |
| 0.098 | 0.039 | 0.098 | Inducible nitric-oxide synthase inhibitor | |||
| 0.061 | 0.004 | 0.061 | Glucocorticoid agonist | 0.034 0.005 DBMET02306 0.029 0.006 DBMET02307 | ||
| 0.168 | 0.113 | 0.168 | Neurotrophic factor enhancer | |||
| 0.057 | 0.003 | 0.057 | Progesterone receptor B antagonist | 0.03 0.005 DBMET02306 0.029 0.005 DBMET02307 | ||
| 0.06 | 0.012 | 0.06 | Parathyroid hormone antagonist | 0.043 0.036 DBMET02306 0.047 0.028 DBMET02307 | ||
| 0.087 | 0.047 | 0.122 | Glycine receptor antagonist | 0.122 0.017 DBMET02307 | DBMET02307 | |
| 0.05 | 0.011 | 0.05 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.171 | 0.133 | 0.376 | Tumour necrosis factor alpha release inhibitor | 0.376 0.031 DBMET02307 | DBMET02307 | |
| 0.041 | 0.004 | 0.041 | Corticosteroid-like | 0.024 0.011 DBMET02306 0.029 0.007 DBMET02307 | ||
| 0.15 | 0.115 | 0.153 | Non-steroidal antiinflammatory agent | 0.153 0.111 DBMET02307 | DBMET02307 | |
| 0.046 | 0.014 | 0.046 | Glucose-6-phosphate dehydrogenase inhibitor | 0.035 0.033 DBMET02307 | ||
| 0.041 | 0.01 | 0.041 | Estrogen-related receptor beta antagonist | |||
| 0.109 | 0.08 | 0.109 | Acetylcholine antagonist | |||
| 0.111 | 0.082 | 0.111 | Cholinergic antagonist | |||
| 0.196 | 0.168 | 0.334 | Cholesterol antagonist | 0.334 0.071 DBMET02307 | DBMET02307 | |
| 0.132 | 0.111 | 0.134 | Melanin inhibitor | 0.134 0.107 DBMET02307 | DBMET02307 | |
| 0.06 | 0.045 | 0.06 | Heme oxygenase stimulant | |||
| 0.024 | 0.011 | 0.024 | Vitamin D receptor antagonist | 0.021 0.017 DBMET02307 | ||
| 0.016 | 0.004 | 0.016 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | |||
| 0.141 | 0.131 | 0.141 | P-glycoprotein inhibitor | |||
| 0.008 | 0.003 | 0.008 | Transcortin receptor antagonist | |||
| 0.016 | 0.012 | 0.016 | Vitamin D receptor agonist | 0.015 0.014 DBMET02306 | ||
| 0.048 | 0.046 | 0.048 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.102 | 0.1 | 0.102 | Tubulin antagonist | |||
| 0.017 | 0.016 | 0.017 | 5-Alpha-reductase 2 inhibitor | |||
| 0.194 | 0.2 | 0.285 | Interleukin 2 agonist | 0.285 0.085 DBMET02307 | DBMET02307 | |
| 0.003 | 0.041 | 0.017 | Antibiotic Macrolide-like | 0.017 0.008 DBMET02307 | DBMET02307 | |
| 0.196 | 0.234 | 0.525 | Antibacterial | 0.302 0.134 DBMET02306 0.525 0.034 DBMET02307 | DBMET02307 | |
| 0.03 | 0.079 | 0.094 | Protein 50S ribosomal subunit inhibitor | 0.094 0.015 DBMET02307 | DBMET02307 | |
| 0.076 | 0.127 | 0.108 | Alkylator | 0.108 0.08 DBMET02307 | DBMET02307 | |
| 0.065 | 0.127 | 0.126 | Protein-tyrosine phosphatase 1B inhibitor | 0.126 0.059 DBMET02306 | DBMET02306 | |
| 0.091 | 0.169 | 0.363 | Angiogenesis stimulant | 0.17 0.11 DBMET02306 0.363 0.029 DBMET02307 | DBMET02307 | |
| 0.085 | 0.177 | 0.143 | Protein-tyrosine phosphatase inhibitor | 0.143 0.086 DBMET02306 | DBMET02306 | |
| 0.067 | 0.162 | 0.148 | Toll-Like receptor 4 antagonist | 0.148 0.022 DBMET02307 | DBMET02307 | |
| 0.122 | 0.223 | 0.272 | DNA damaging | 0.272 0.069 DBMET02307 | DBMET02307 | |
| 0.058 | 0.16 | 0.125 | Transcription factor NF kappa B stimulant | 0.125 0.023 DBMET02307 | DBMET02307 | |
| 0.011 | 0.117 | 0.028 | Protein 30S ribosomal subunit inhibitor | 0.028 0.014 DBMET02307 | DBMET02307 | |
| 0.042 | 0.166 | 0.086 | Topoisomerase I inhibitor | 0.086 0.083 DBMET02307 | DBMET02307 | |
| 0.089 | 0.23 | 0.202 | Interleukin 6 antagonist | 0.202 0.039 DBMET02307 | DBMET02307 | |
| 0.076 | 0.267 | 0.209 | Hypolipemic | 0.209 0.088 DBMET02307 | DBMET02307 | |
| 0.079 | 0.278 | 0.217 | Free radical scavenger | 0.217 0.085 DBMET02307 | DBMET02307 | |
| 0.062 | 0.312 | 0.35 | Immunostimulant | 0.35 0.064 DBMET02307 | DBMET02307 | |
| 0.093 | 0.362 | 0.415 | Antithrombotic | 0.415 0.046 DBMET02307 | DBMET02307 | |
| 0.014 | 0.365 | 0.056 | Antibiotic Aminoglycoside-like | 0.056 0.01 DBMET02307 | DBMET02307 | |
| 0.03 | 0.41 | 0.099 | Amylase inhibitor | 0.099 0.097 DBMET02307 | DBMET02307 | |
| 0.071 | 0.476 | 0.283 | Immunomodulator | 0.283 0.092 DBMET02307 | DBMET02307 | |
| 0.085 | 0.555 | 0.275 | Peptidyltransferase inhibitor | 0.275 0.035 DBMET02307 | DBMET02307 | |
| 0.037 | 0.69 | 0.305 | Cyclophilin D inhibitor | 0.305 0.158 DBMET02307 | DBMET02307 | |
| 0.003 | 0.895 | 0.034 | AMPA receptor agonist | 0.034 0.028 DBMET02306 | DBMET02306 | |
| 0.003 | 0.915 | 0.183 | Selectin antagonist | 0.183 0.013 DBMET02307 | DBMET02307 | |
| 0.002 | 0.927 | 0.02 | Elastase 2 inhibitor | 0.02 0.018 DBMET02306 | DBMET02306 | |
| 0.002 | 0.927 | 0.02 | Elastase 2A inhibitor | 0.02 0.018 DBMET02306 | DBMET02306 | |
| 0.005 | 0.972 | 0.161 | CXC chemokine 1 receptor antagonist | 0.161 0.004 DBMET02306 | DBMET02306 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |